A 2025 case-control study conducted by researchers at Guangxi Medical University presents a machine learning model, particularly using a Random Forest, to predict liver cancer risk in chronic hepatitis B. Key markers such as AST/ALT, BLR, and AFP stand out. Consider monitoring these parameters to facilitate timely clinical interventions.